Download Citation
Article Source:
A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia
García-Gutiérrez V,
Gómez-Casares MT,
Puerta JM,
Alonso-Domínguez JM,
Osorio S,
et al.
(2017)
A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.
PLOS ONE 12(3): e0173532.
https://doi.org/10.1371/journal.pone.0173532